Cambre Jerome 4

What Happened Jerome Cambre, Vice President of Sales at Viemed Healthcare (VMD), vested/converted derivative awards on January 21, 2026 that resulted in the acquisition of a total of 14,649 underlying shares (11,719 + 2,930). To satisfy tax withholding and a cash settlement, 3,827 shares were withheld by the issuer (tax withholding) valued at $28,664 (3,827 × $7.49) and 2,930 shares were tendered back to the company for cash worth $21,946 (2,930 × $7.49). After those withholdings/settlements, the net increase in Cambre’s shares is 7,892 shares (14,649 acquired minus 3,827 withheld and 2,930 tendered).

Key Details

• Transaction date: January 21, 2026; Form filed January 23, 2026 (timely within usual 2-business-day window).
• Per-share value used: $7.49 (market close price on Jan 21, 2026) — used to report cash amounts.
• Tax withholding: 3,827 shares withheld to satisfy tax liability (reported as "F" – payment of tax liability) — $28,664.
• Cash settlement / disposition to issuer: 2,930 shares surrendered to the issuer for cash — $21,946.
• Awards involved: Restricted Stock Units (RSUs) and phantom share units (derivative awards). RSUs = 1 share each; phantom shares are cash-settled equivalents (see footnotes F1–F6).
• Shares owned after transaction: Not specified in the provided excerpt of the filing.
• Filing timeliness: Filed 2 days after the transaction (appears timely).

Context

• These entries reflect routine vesting/conversion of equity awards (RSUs and phantom share units) and cashless settlement activity — not an open-market sale to a third party. The phantom-share settlement is reported as a simultaneous acquisition of underlying shares and disposition back to the company for cash.
• Withholding of shares to cover taxes and surrendering shares for cash settlement are common, administrative steps and do not by themselves indicate insider sentiment about the company.